Monica Bertagnolli
Monica Bertagnolli | |
---|---|
Born | 1959 (age 62–63) |
Education | |
Scientific career | |
Fields | |
Institutions | |
Website | www |
Monica Bertagnolli (born 1959) is an American surgical oncologist at Dana–Farber Cancer Institute and the Richard E. Wilson Professor of Surgery at Harvard Medical School.[1] She advocates for inclusion of rural communities in clinical studies and serves as Chair of the Alliance for Clinical Trials in Oncology.[2] Bertagnolli specializes in the treatment of tumors from gastrointestinal diseases.[3] She is the former President of the American Society of Clinical Oncology and was elected Fellow of the National Academy of Medicine in 2021.
Early life and education[]
Bertagnolli grew up on a cattle ranch in Wyoming.[4][5] Her parents were first generation French and Italian immigrants.[4] She earned a BE in biochemical engineering from Princeton University.[6][7] She studied medicine at the University of Utah School of Medicine and did her surgical residency at Brigham and Women's Hospital. She became board certified in 1993.[8]
Research and career[]
In 1994, Bertagnolli began as an associate surgeon at the Strang Cancer Prevention Center and attending surgeon at NewYork-Presbyterian Hospital–Cornell.[6] She joined the faculty at Harvard Medical School in 1999 and was appointed at Dana–Farber Cancer Institute in 2000.[6] Bertagnolli specializes in the treatment of tumors from gastrointestinal diseases and is an expert in treating soft-tissue sarcoma.[4] She became the Chief of Surgical Oncology at the Dana-Farber Cancer Institute in 2007, and was the first woman to hold such a position.[4] Bertagnolli's laboratory at the Dana-Farber / Harvard Cancer Center studies the role of Adenomatous polyposis coli (APC) mutations in colorectal carcinogenesis through animal studies and human clinical trials.[9]
Awards and honors[]
Her honors and awards include:
- 2011 Partners Healthcare Partners in Excellence Award[citation needed]
- 2015 Cancer Charles H. Sanders Life Sciences Award[10]
- 2018 Appointed President of the American Society of Clinical Oncology[11]
- 2021 Elected to the National Academy of Medicine[12][13]
- 2021 Appointed to the Board of Directors of American Cancer Society[14]
Selected publications[]
Her publications[1] include:
- Molecular origins of cancer: Molecular basis of colorectal cancer[15]
- Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention[16]
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq[17]
Personal life[]
Bertagnolli is married with two sons.[4]
References[]
- ^ a b Monica Bertagnolli publications from Europe PubMed Central
- ^ Dutchen, Stephanie. "In the Picture". Harvard Medicine magazine. Retrieved October 24, 2021.
- ^ www
.dana-farber .org /find-a-doctor /monica-m-bertagnolli / - ^ a b c d e "Hub's Humble Cancer Hero ; Surgical `Superstar' Dr. Monica Bertagnolli Tackles the Tough Cases". redorbit.com. June 24, 2007. Retrieved October 24, 2021.
- ^ "Women's History Month - Monica Bertagnnolli, MD". AAUW California. March 3, 2018. Retrieved October 24, 2021.
- ^ a b c "Monica M. Bertagnolli, MD, FACS, FASCO". ASCO. Retrieved October 24, 2021.
- ^ Piana, Ronald (June 3, 2018). "Monica M. Bertagnolli, MD, FASCO, a Cattle Rancher's Daughter, Becomes ASCO President". Retrieved October 24, 2021.
- ^ "Monica M. Bertagnolli, MD - Dana-Farber Cancer Institute | Boston, MA". dana-farber.org. Retrieved October 24, 2021.
- ^ "Monica M. Bertagnolli, MD". Dana-Farber / Harvard Cancer Center. Retrieved October 24, 2021.
- ^ "2015 Recipients of "The Charlie" – Pfizer and The Alliance for Clinical Trials in Oncology | CEO Roundtable on Cancer". ceoroundtableoncancer.org. Retrieved October 24, 2021.
- ^ "ASCO elects Dana-Farber/Brigham and Women's Monica Bertagnolli, MD, as 2018-19 president - Dana-Farber Cancer Institute | Boston, MA". dana-farber.org. Retrieved October 24, 2021.
- ^ "National Academy of Medicine Elects 100 New Members". National Academy of Medicine. October 18, 2021. Retrieved October 24, 2021.
- ^ "Two Dana-Farber faculty elected to National Academy of Medicine - Dana-Farber Cancer Institute | Boston, MA". dana-farber.org. Retrieved October 24, 2021.
- ^ "Monica Bertagnolli Bio". cancer.org. Retrieved October 24, 2021.
- ^ Sanford D Markowitz; Monica M Bertagnolli (December 17, 2009). "Molecular origins of cancer: Molecular basis of colorectal cancer". The New England Journal of Medicine. 361 (25): 2449–60. doi:10.1056/NEJMRA0804588. ISSN 0028-4793. PMC 2843693. PMID 20018966. Wikidata Q24617331.
- ^ Solomon SD; McMurray JJ; Pfeffer MA; et al. (March 17, 2005). "Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention". The New England Journal of Medicine. 352 (11): 1071–80. doi:10.1056/NEJMOA050405. ISSN 0028-4793. PMID 15713944. Wikidata Q29620087.
- ^ Itay Tirosh; Benjamin Izar; Sanjay M Prakadan; et al. (April 1, 2016). "Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq". Science. 352 (6282): 189–196. doi:10.1126/SCIENCE.AAD0501. ISSN 0036-8075. PMC 4944528. PMID 27124452. Wikidata Q37094024.
- Women oncologists
- American surgeons
- Harvard Medical School faculty
- American Cancer Society people
- Living people
- 1959 births